PAMNEU - Memory in Neurology

Charles University, Czech Republic

Status: Active, not recruiting

Conditions: Cognitive Impairment

Study type: Observational

Funder types: Other

Identifiers

NCT06154564

PAMNEU

Details and patient eligibility

About

Memory in Neurology project (PAMNEU) aims to map the distribution and severity of cognitive impairment in patients of outpatient neurologic offices across the geographical area of the Czech Republic. 1000 patients in 50 neurologic offices will undergo cognitive tests (ALBA and PICNIR) and psychometric scales (FAQ-CZ and GDS-CZ) to asses their functional state and depressive symptoms.

The trial's primary goal is to assess the distribution of cognitive impairment among diagnostic groups in neurologic care according to the ICD-10. Additionally, the feasibility of ALBA and PICNIR methods to uncover previously undiagnosed cognitive impairments will be evaluated.

Enrollment: 600 estimated patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Dispensarization of at least six months in an outpatient neurologic office with an ICD-10 diagnosis
• Age>=50
• Permanent residency in the geographical area of the Czech Republic

Exclusion criteria

• Diagnosis of mental retardation (F70-F79) according to ICD-10
• Refusal to sign the informed consent and consent with GDPR
• Uncorrected visual impairment
• Uncorrected auditory impairment
• Impairment of hand movement preventing the patient from filling in the questionnaires.
• Inability to participate in the project

Trial design

600 participants in 1 patient group

Observed group

Description:

No intervention will be administered on behalf of the project. The participants will be tested using ALBA and PICNIR (non-invasive) cognitive tests, and further FAQ-CZ and GDS-CZ questionnaires will be administered.